Yıl: 2018 Cilt: 3 Sayı: 3 Sayfa Aralığı: 168 - 172 Metin Dili: İngilizce DOI: 10.5152/cjms.2018.647 İndeks Tarihi: 01-09-2020

Can Preoperative Complete Blood Count Parameters Be Used as Predictive Markers for Lymph Node Metastasis in Endometrial Carcinomas?

Öz:
BACKGROUND/AIMSTo investigate the clinical utility of complete blood count (CBC) parameters in the preoperative diagnosis of lymph node involvement(LNI) in endometrial carcinomas (ECs).MATERIAL and METHODSWe conducted a retrospective study of 159 patients with ECs who underwent complete staging surgery at a tertiary center between2007 and 2017. After demographic characteristics and preoperative CBC parameters were retrieved from the patients’ medical records,the patients were grouped according to lymph node status (positive and negative) and compared. Variables with p<0.05 were includedin the logistic regression analysis, and receiver operating characteristic curve analysis was used to determine the cut-off values forpredicting LNI.RESULTSThe mean age of the patients was 59.1 years, and 14 (8.8%) patients had LNI. The mean white blood cell, neutrophil, and platelet counts;plateletcrit level; and neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios were significantly higher in patients with LNI. Logisticregression analysis identified an independent association between increased neutrophil count and LNI (odds ratio 5.12; p<0.05). Theoptimal cut-off value was 4.85 (×103/μL) (sensitivity, 77.4% and specificity, 74.2%). A cut-off of 6.25 (×103/μL) was used to identify LNI with100% specificity.CONCLUSIONAn increased neutrophil count can be considered a useful additional tool for the preoperative diagnosis of LNI.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin 2015; 65: 87-108. [CrossRef]
  • 2. Creasman WT, Odicino F, Maisonneuve P, Quinn MA, Beller U, Benedet JL, et al. Carcinoma of the corpus uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet 2006; 95(Suppl 1): S105-43 [CrossRef]
  • 3. Werner HM, Trovik J, Marcickiewicz J, Tingulstad S, Staff AC, Amant F, et al. Revision of FIGO surgical staging in 2009 for endometrial cancer validates to improve risk stratification. Gynecol Oncol 2012; 125: 103-8. [CrossRef]
  • 4. Practice Bulletin No. 149: Endometrial cancer. Obstet Gynecol 2015; 125: 1006-26. [CrossRef]
  • 5. Milam MR, Java J, Walker JL, Metzinger DS, Parker LP, Coleman RL, et al. Nodal metastasis risk in endometrioid endometrial cancer. Obstet Gynecol 2012; 119: 286-92. [CrossRef]
  • 6. Frost JA, Webster KE, Bryant A, Morrison J. Lymphadenectomy for the management of endometrial cancer. Cochrane Database Syst Rev 2015; 10: CD007585. [CrossRef]
  • 7. Kang S, Nam JH, Bae DS, Kim JW, Kim MH, Chen X, et al. Preoperative assessment of lymph node metastasis in endometrial cancer: A Korean Gynecologic Oncology Group study. Cancer 2017; 123: 263- 72. [CrossRef]
  • 8. Vergas R, Rauh-Hain JA, Clemmer J, Clark RM, Goodman A, Growdon WB, et al. Tumor size, depth of invasion, and histologic grade as prognostic factors of lymph node involvement in endometrial cancer: a SEER analysis. Gynecol Oncol 2014; 133: 216-20. [CrossRef]
  • 9. Andreano A, Rechichi G, Rebora P, Sironi S, Valsecchi MG, Galimberti S. MR diffusion imaging for preoperative staging of myometrial invasion in patients with endometrial cancer: a systematic review and meta-analysis. Eur Radiol 2014; 24: 1327-38. [CrossRef]
  • 10. Ertas IE, Gungorduk K, Akman L, Ozdemir A, Terek MC, Ozsaran A, et al. Can preoperative neutrophil:lymphocyte and platelet:lymphocyte ratios be used as predictive marker for lymph node metastasis in squamous cell carcinoma of the vulva? Eur J Obstet Gynecol Reprod Biol 2013; 171: 138-42. [CrossRef]
  • 11. D’Andrea D, Moschini M, Gust KM, Abufaraj M, Özsoy M, Mathieu R, et al. Lymphocyte-to-monocyte ratio and neutrophil-to-lymphocyte ratio as biomarkers for predicting lymph node metastasis and survival in patients treated with radical cyctectomy. J Surg Oncol 2017; 115: 455-61. [CrossRef]
  • 12. Kemal Y, Demirag G, Baş B, Önem S, Teker F, Yücel İ. The value of red blood cell distribution width in endometrial cancer. Clin Chem Lab Med 2015; 53: 823-7. [CrossRef]
  • 13. Ekici H, Malatyalioglu E, Kokcu A, Kurtoglu E, Tosun M, Celik H. Do leukocyte and platelet counts have benefit for preoperative evaluation of endometrial cancer? Asian Pac J Cancer Prev 2015; 16: 5305-10. [CrossRef]
  • 14. Karateke A, Kaplanoglu N, Baloglu A. Relations of platelet indices with endometrial hyperplasia and endometrial cancer. Asian Pac J Cancer Prev 2015; 16: 4905-8. [CrossRef]
  • 15. Acmaz G, Aksoy H, Unal D, Ozyurt S, Cingillioglu B, Aksoy U, et al. Are neutrophil/lymphocyte and platelet/lymphocyte ratios associated with endometrial precancerous and cancerous lesions in patients with abnormal uterine bleeding? Asian Pac J Cancer Prev 2014; 15: 1689-92. [CrossRef]
  • 16. Ural ÜM, Şehitoğlu İ, Tekin YB, Şahin FK. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios in patients with endometrial hyperplasia and endometrial cancer. J Obstet Gynaecol Res 2015; 41: 445-8. [CrossRef]
  • 17. Oge T, Yalcin OT, Ozalp SS, Isikci T. Platelet volume as a parameter for platelet activation in patients with endometrial cancer. J Obstet Gynaecol 2013; 33: 301-4. [CrossRef]
  • 18. Takahashi R, Mabuchi S, Kawano M, Sasano T, Matsumoto Y, Kuroda H, et al. Prognostic significance of systemic neutrophil and leukocyte alterations in surgically treated endometrial cancer patients: a mono institutional study. Gynecol Oncol 2015; 137: 112-8. [CrossRef]
  • 19. Takahashi R, Mabuchi S, Kuroda H, Kozasa K, Yokoi E, Matsumoto Y, et al. The significance of pretreatment thrombocytosis and its association with neutrophilia in patients with surgically treated endometrial cancer. Int J Gynecol Cancer 2017; 27: 1399-407. [CrossRef]
  • 20. Suh DH, Kim HS, Chung HH, Kim JW, Park NH, Song YS, Kang SB. Pre-operative systemic inflammatory response markers in predicting lymph node metastasis in endometrioid endometrial adenocarcinoma. Eur J Obstet Gynecol Reprod Biol 2012; 162: 206-10. [CrossRef]
  • 21. Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature 2008; 454: 436-44. [CrossRef]
  • 22. Zhao W, Wang P, Jia H, Chen M, Gu X, Liu M, et al. Neutrophil count and percentage: potential independent prognostic indicators for advanced cancer patients in a palliative care setting. Oncotarget 2017; 8: 64499-508. [CrossRef]
  • 23. Uribe-Querol E, Rosales C. Neutrophils in cancer: two sides of the same coin. J Immunol Res 2015; 2015: 983698. [CrossRef]
  • 24. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011; 144: 646-74. doi: 10.1016/j.cell.2011.02.013. [CrossRef]
APA Tas E, özgen e, Yavuz A (2018). Can Preoperative Complete Blood Count Parameters Be Used as Predictive Markers for Lymph Node Metastasis in Endometrial Carcinomas?. , 168 - 172. 10.5152/cjms.2018.647
Chicago Tas Emre Erdem,özgen eyyüp,Yavuz Ayse Filiz Can Preoperative Complete Blood Count Parameters Be Used as Predictive Markers for Lymph Node Metastasis in Endometrial Carcinomas?. (2018): 168 - 172. 10.5152/cjms.2018.647
MLA Tas Emre Erdem,özgen eyyüp,Yavuz Ayse Filiz Can Preoperative Complete Blood Count Parameters Be Used as Predictive Markers for Lymph Node Metastasis in Endometrial Carcinomas?. , 2018, ss.168 - 172. 10.5152/cjms.2018.647
AMA Tas E,özgen e,Yavuz A Can Preoperative Complete Blood Count Parameters Be Used as Predictive Markers for Lymph Node Metastasis in Endometrial Carcinomas?. . 2018; 168 - 172. 10.5152/cjms.2018.647
Vancouver Tas E,özgen e,Yavuz A Can Preoperative Complete Blood Count Parameters Be Used as Predictive Markers for Lymph Node Metastasis in Endometrial Carcinomas?. . 2018; 168 - 172. 10.5152/cjms.2018.647
IEEE Tas E,özgen e,Yavuz A "Can Preoperative Complete Blood Count Parameters Be Used as Predictive Markers for Lymph Node Metastasis in Endometrial Carcinomas?." , ss.168 - 172, 2018. 10.5152/cjms.2018.647
ISNAD Tas, Emre Erdem vd. "Can Preoperative Complete Blood Count Parameters Be Used as Predictive Markers for Lymph Node Metastasis in Endometrial Carcinomas?". (2018), 168-172. https://doi.org/10.5152/cjms.2018.647
APA Tas E, özgen e, Yavuz A (2018). Can Preoperative Complete Blood Count Parameters Be Used as Predictive Markers for Lymph Node Metastasis in Endometrial Carcinomas?. Cyprus Journal of Medical Sciences, 3(3), 168 - 172. 10.5152/cjms.2018.647
Chicago Tas Emre Erdem,özgen eyyüp,Yavuz Ayse Filiz Can Preoperative Complete Blood Count Parameters Be Used as Predictive Markers for Lymph Node Metastasis in Endometrial Carcinomas?. Cyprus Journal of Medical Sciences 3, no.3 (2018): 168 - 172. 10.5152/cjms.2018.647
MLA Tas Emre Erdem,özgen eyyüp,Yavuz Ayse Filiz Can Preoperative Complete Blood Count Parameters Be Used as Predictive Markers for Lymph Node Metastasis in Endometrial Carcinomas?. Cyprus Journal of Medical Sciences, vol.3, no.3, 2018, ss.168 - 172. 10.5152/cjms.2018.647
AMA Tas E,özgen e,Yavuz A Can Preoperative Complete Blood Count Parameters Be Used as Predictive Markers for Lymph Node Metastasis in Endometrial Carcinomas?. Cyprus Journal of Medical Sciences. 2018; 3(3): 168 - 172. 10.5152/cjms.2018.647
Vancouver Tas E,özgen e,Yavuz A Can Preoperative Complete Blood Count Parameters Be Used as Predictive Markers for Lymph Node Metastasis in Endometrial Carcinomas?. Cyprus Journal of Medical Sciences. 2018; 3(3): 168 - 172. 10.5152/cjms.2018.647
IEEE Tas E,özgen e,Yavuz A "Can Preoperative Complete Blood Count Parameters Be Used as Predictive Markers for Lymph Node Metastasis in Endometrial Carcinomas?." Cyprus Journal of Medical Sciences, 3, ss.168 - 172, 2018. 10.5152/cjms.2018.647
ISNAD Tas, Emre Erdem vd. "Can Preoperative Complete Blood Count Parameters Be Used as Predictive Markers for Lymph Node Metastasis in Endometrial Carcinomas?". Cyprus Journal of Medical Sciences 3/3 (2018), 168-172. https://doi.org/10.5152/cjms.2018.647